• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,109
3,508
3,391
2,812
2,749

COUNTRY

2,358
867
275
262
226

CATEGORIES

  • 951
  • 173
  • 114
  • 290
    • 49
  • 498
  • 259
  • 237
  • 56
  • 62
  • 839
  • 1,484
  • 821
  • 18
  • 487
  • 1,411
  • 2,352
    • 85
    • 124
    • 66
    • 65
    • 37
    • 36
    • 12
    • 12
    • 12
    • 18
  • 23
  • 267
  • 35
  • 2,588
SHOW ALL…

PRICE

2,438
8,073
16,147
28,484

PUBLISHED

2,283
6,797
12,231
28,484

PRODUCT TYPE

26,000
1,058
1,047
163
81
61
21
21
16
9
6
1

Pharmaceuticals

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE

Gastrointestinal Radiation Toxicity - Pipeline Review, H2 2014

Gastrointestinal Radiation Toxicity - Pipeline Review, H2 2014 Summary This, ‘Gastrointestinal Radiation Toxicity - Pipeline Review, H2 2014’, provides an overview of the Gastrointestinal Radiation...

December 2014
FROM

Paralysis - Pipeline Review, H2 2014

Paralysis - Pipeline Review, H2 2014 Summary This, ‘Paralysis - Pipeline Review, H2 2014’, provides an overview of the Paralysis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Ureter Cancer - Pipeline Review, H2 2014

Ureter Cancer - Pipeline Review, H2 2014 Summary This, ‘Ureter Cancer - Pipeline Review, H2 2014’, provides an overview of the Ureter Cancer’s therapeutic pipeline. This report provides comprehensive...

December 2014
FROM

Pheochromocytoma - Pipeline Review, H2 2014

Pheochromocytoma - Pipeline Review, H2 2014 Summary This, ‘Pheochromocytoma - Pipeline Review, H2 2014’, provides an overview of the Pheochromocytoma’s therapeutic pipeline. This report provides...

December 2014
FROM

Trauma - Pipeline Review, H2 2014

Trauma - Pipeline Review, H2 2014 Summary This, ‘Trauma - Pipeline Review, H2 2014’, provides an overview of the Trauma’s therapeutic pipeline. This report provides comprehensive information on the...

December 2014
FROM

Vasculitis - Pipeline Review, H2 2014

Vasculitis - Pipeline Review, H2 2014 Summary This, ‘Vasculitis - Pipeline Review, H2 2014’, provides an overview of the Vasculitis’s therapeutic pipeline. This report provides comprehensive information...

December 2014
FROM

Pulmonary Fibrosis - Pipeline Review, H2 2014

Pulmonary Fibrosis - Pipeline Review, H2 2014 Summary This, ‘Pulmonary Fibrosis - Pipeline Review, H2 2014’, provides an overview of the Pulmonary Fibrosis’s therapeutic pipeline. This report provides...

December 2014
FROM

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints....

December 2014
FROM

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Irritable Bowel Syndrome - US Drug Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with...

December 2014
FROM

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Baricitinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Filgotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It...

December 2014
FROM

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Decernotinib (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ....

December 2014
FROM

Irribow (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023

Irribow (Irritable Bowel Syndrome) - Forecast and Market Analysis to 2023 Summary Irritable Bowel Syndrome (IBS) is a common disorder characterized by abdominal discomfort associated with altered...

December 2014
FROM

Frontier Pharma: Liver Cancer - Identifying and Commercializing First-in-Class Innovation

Summary The liver cancer pipeline contains 238 products in active development, approximately 47% of which are first-in-class. The percentage of the pipeline devoted to innovative products is considerably...

December 2014
FROM

Frontier Pharma: Antibiotics - Identifying and Commercializing First-in-Class Innovation

Summary The antibiotics pipeline is very active, with 741 products in development. Of these, the majority (85%) are at the Discovery or Preclinical stages and have not yet entered human trials. Such...

December 2014
FROM

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable autoimmune disease that primarily affects joints. It is characterized by synovial inflammation and gradual bone...

December 2014
FROM

Annual Report Analysis of Listed Vitamin Companies in China

Purpose of report: In order to clearly describe China's vitamin industry, a great deal of information has been collected in various ways. In this report, development situation of vitamin listed companies...

December 2014
FROM
Flow Chemistry Market for Pharmaceutical, Chemical, Academic & Industrial Research, Petrochemical and Other End-user Industries - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020  Flow Chemistry Market for Pharmaceutical, Chemical, Academic & Industrial Research, Petrochemical and Other End-user Industries - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020 - Product Thumbnail Image

Flow Chemistry Market for Pharmaceutical, Chemical, Academic & Industrial Research, Petrochemical and Other End-user Industries - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

'Flow Chemistry (Microreactor Systems, Continuous Stirred Tank Reactor, Plug Flow Reactor and Other Products) Market for Pharmaceutical, Chemical, Academic & Industrial Research, Petrochemical and Other...

December 2014

2015 Global Laboratory Products Purchasing Trends

Readers of the Lab Manager Magazine were invited to participate in an online survey in September 2014. To qualify for survey participation, readers were required to play a role in their laboratory’s...

December 2014
FROM

Handbook of Health Survey Methods. Wiley Handbooks in Survey Methodology

A comprehensive guidebook to the current methodologies and practices used in health surveys A unique and self-contained resource, Handbook of Health Survey Methods presents techniques necessary for...

December 2014
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S